ABSI vs BIIB: Which Stock is Better?

Side-by-side comparison of Absci Corp and Biogen Inc in 2026

Comparison Updated:

ABSI

Absci Corp

$2.90

BIIB

Biogen Inc

$165.38

Key Metrics Comparison

MetricABSIBIIBWinner
Market Cap$454.12M$24.26BBIIB
P/E RatioN/A15.09BIIB
EPS (TTM)$N/A$10.96BIIB
Revenue Growth-0.8%0.0%BIIB
Gross Margin-2495.0%76.6%BIIB

Analyze ABSI

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ABSI or BIIB a better investment?

Comparing ABSI and BIIB: Absci Corp has a market cap of $454.12M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ABSI and BIIB?

ABSI (Absci Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ABSI or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ABSI or BIIB?

BIIB has higher revenue growth at 0.0% vs -0.8% for ABSI.

Which company is more profitable: ABSI or BIIB?

Biogen Inc (BIIB) has higher gross margins at 76.6% compared to -2495.0% for ABSI.

Which is the larger company: ABSI or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $454.12M for ABSI.

Should I buy ABSI or BIIB in 2026?

Both ABSI and BIIB have investment merit. ABSI trades at $2.90 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ABSI and BIIB stock?

Key differences: Market Cap ($454.12M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (-2495.0% vs 76.6%).

Popular Stock Comparisons